DD
36
-4
CAG
48
-5
TDC
26
-4
SO
57
-2
MPC
47
3
FE
45
-7
KSS
26
-3
OXY
49
3
UA
48
-2
IBM
57
2
WHR
47
-3
XRAY
17
-2
DIS
72
3
MOS
50
-2
NTAP
39
2
CRM
42
2
MCO
71
3
EXPE
78
-2
IRM
44
-5
PSX
44
-3
DD
36
-4
CAG
48
-5
TDC
26
-4
SO
57
-2
MPC
47
3
FE
45
-7
KSS
26
-3
OXY
49
3
UA
48
-2
IBM
57
2
WHR
47
-3
XRAY
17
-2
DIS
72
3
MOS
50
-2
NTAP
39
2
CRM
42
2
MCO
71
3
EXPE
78
-2
IRM
44
-5
PSX
44
-3
Financhill
Back

NovaBay Pharmaceuticals Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
36

NBY
NovaBay Pharmaceuticals

Last Price:
$0.61
Seasonality Move:
0.89%
Sell
6

CRSP
CRISPR Therapeutics AG

Last Price:
$39.20
Seasonality Move:
13.67%
Sell
36
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.61. The Score for NBY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $40.89. The Score for CRSP is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $40.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.98 Sell
Chaikin Money Flow: -39214 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.64) Sell
Bollinger Bands (100): (0.58 - 0.7) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.23 Buy
Relative Strength Index (14 RSI): 43.54 Sell
Chaikin Money Flow: -1431436 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.96 - 47.82) Sell
Bollinger Bands (100): (40.53 - 49.17) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Sell
20-day SMA: 0.62 Sell
50-day SMA: 0.66 Sell
200-day SMA: 0.93 Sell
8-day EMA: 0.62 Sell
20-day EMA: 0.62 Sell
50-day EMA: 0.64 Sell
200-day EMA: 2.87 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.72 Sell
20-day SMA: 42.82 Sell
50-day SMA: 42.77 Sell
200-day SMA: 48.27 Sell
8-day EMA: 26.3 Buy
20-day EMA: 13.68 Buy
50-day EMA: 6.13 Buy
200-day EMA: 1.63 Buy

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):